Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Life Science

• Publication date

  2004-01-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.LFS.2003.07.032PMID 14697405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of HMG CoA reductase inhibition on small GTPases in the heart.

  2002cited by this paper
• Myocardial changes after spironolactone in spontaneous hypertensive rats. A laser scanning confocal microscopy study 1

  2002cited by this paper
• Association of Pravastatin and Left Ventricular Mass in Hypercholesterolemic Patients: Role of 8-Iso-Prostaglandin F2&agr; Formation

  2002cited by this paper
• Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box.

  2002cited by this paper
• Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

  2002cited by this paper
• Heart Remodeling in the Hereditary Hypertriglyceridemic Rat

  2002cited by this paper
• Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study.

  2002cited by this paper
• Physiologic and pathologic myocardial hypertrophy--physiologic and pathologic regression of hypertrophy?

  2002cited by this paper
• Simvastatin inhibits noradrenaline‐induced hypertrophy of cultured neonatal rat cardiomyocytes

  2001cited by this paper
• Chronic inhibition of NO synthesis per se promotes structural intimal remodeling of the rat aorta

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition.

  2001cited by this paper
• HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen Species

  2001cited by this paper
• Amelioration of Angiotensin II–Induced Cardiac Injury by a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor

  2001cited by this paper
• Reversal of cardiovascular remodelling with candesartan

  2001cited by this paper
• Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.

  2001cited by this paper
• Stereology of cardiac hypertrophy induced by NO blockade in rats treated with enalapril and verapamil.

  2001cited by this paper
• Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy

  2001cited by this paper
• Deficit of coenzyme Q in heart and liver mitochondria of rats with streptozotocin-induced diabetes.

  2000cited by this paper
• The potential role of nitric oxide in the hypertrophic growth of the left ventricle.

  2000cited by this paper
• Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.

  2000cited by this paper
• SIMVASTATIN INHIBITS CARDIAC HYPERTROPHY AND ANGIOTENSIN‐CONVERTING ENZYME ACTIVITY IN RATS WITH AORTIC STENOSIS

  1999cited by this paper
• L-NAME-induced protein remodeling and fibrosis in the rat heart.

  1999cited by this paper
• Effect of Captopril in L‐Name‐Induced Hypertension on the Rat Myocardium, Aorta, Brain and Kidney

  1999cited by this paper
• Sympathetic functions in N: modulation by the renin-angiotensin systemg: modulation by the renin-angiotensin system-nitro-l-arginine-methylester-induced hypertension: modulation by the renin-angiotensin system

  1998cited by this paper
• Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism.

  1998cited by this paper
• Participation of coenzyme Q10 in the rejection development of the transplanted heart: a clinical study.

  1998cited by this paper
• Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

  1998cited by this paper
• Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland.

  1998cited by this paper
• Sympathetic functions in NG‐nitro‐L‐arginine‐methylester‐induced hypertension: modulation by the renin‐angiotensin system

  1998cited by this paper
• Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase*

  1998cited by this paper
• Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.

  1997cited by this paper
• Basal nitric oxide synthesis in essential hypertension.

  1997cited by this paper
• Rho GTPases and signaling networks.

  1997cited by this paper
• Chronic inhibition of NO synthesis produces myocardial fibrosis and arterial media hyperplasia.

  1997cited by this paper
• Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.

  1997cited by this paper
• Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril.

  1996cited by this paper
• Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats.

  1996cited by this paper
• Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.

  1996cited by this paper
• Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide-deficient hypertension.

  1996cited by this paper
• Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.

  1996cited by this paper
• Left ventricular hypertrophy regression as a process with variable biological implications.

  1996cited by this paper
• Inhibition of NO synthase in the posterior hypothalamus increases blood pressure in the rat.

  1995cited by this paper
• Pathophysiological principles of the relation between myocardial hypertrophy of the left ventricle and its regression.

  1994cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

  1990cited by this paper
• Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions.

  1986cited by this paper
• Role of the Macula Densa in Renin Release

  1985cited by this paper

• Hydrogen sulphide as a potential contributer to cardiovascular protection with sodium-glucose cotransporter 2 inhibition.

  2026cites this paper
• Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease

  2024cites this paper
• Therapeutic Effects of Statins: Promising drug for Topical and Transdermal Administration.

  2023cites this paper
• Targeted Strategy in Lipid-Lowering Therapy

  2022cites this paper
• Combined Therapy with Simvastatin- and Coenzyme-Q10-Loaded Nanoparticles Upregulates the Akt-eNOS Pathway in Experimental Metabolic Syndrome

  2022cites this paper
• Cardiovascular therapeutics: A new potential for anxiety treatment?

  2022cites this paper
• The Effects of Apitherapeutic Agents on Oxidative Stress in Serum Metabolic Parameters of Hypertensive Rats Created by Nitric Oxide Synthase Inhibited

  2021cites this paper
• Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension

  2020cites this paper
• Animal models in antihypertensive drug development research

  2020cites this paper
• Ivabradine does not impair anxiety-like behavior and memory in both healthy and L-NAME-induced hypertensive rats.

  2018cites this paper
• Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension

  2018cites this paper
• Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension

  2018cites this paper
• Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril

  2017cites this paper
• Celecoxib aggravates cardiac apoptosis in L-NAME-induced pressure overload model in rats: Immunohistochemical determination of cardiac caspase-3, Mcl-1, Bax and Bcl-2.

  2017cites this paper
• Prevention of cardiac dysfunction, kidney fibrosis and lipid metabolic alterations in l-NAME hypertensive rats by sinapic acid--Role of HMG-CoA reductase.

  2016cites this paper
• Effect of ivabradine, captopril and melatonin on the behaviour of rats in L-nitro-arginine methyl ester-induced hypertension.

  2016cites this paper
• Structural alterations in rat myocardium induced by chronic l-arginine and l-NAME supplementation

  2016cites this paper
• Influence of periostin-positive cell-specific Klf5 deletion on aortic thickening in DOCA-salt hypertensive mice

  2016cites this paper
• Hypertension and Cardiovascular Remodelling in Rats Exposed to Continuous Light: Protection by ACE-Inhibition and Melatonin

  2014cites this paper
• Multiplexed immunoassays for simultaneous quantification of cardiovascular biomarkers in the model of H(G)-nitro-L-arginine methylester (L-NAME) hypertensive rat.

  2013cites this paper
• Experimental models of melatonin-deficient hypertension.

  2013cites this paper
• Effect of captopril and melatonin on fibrotic rebuilding of the aorta in 24 hour light-induced hypertension.

  2013cites this paper
• L-NAME in the cardiovascular system — nitric oxide synthase activator?

  2012cites this paper
• Effect of Viscum articulatum Burm. (Loranthaceae) in Nω-nitro-L-arginine methyl ester induced hypertension and renal dysfunction.

  2012cites this paper
• Potential role of statins on wound healing: review of the literature

  2012cites this paper
• Atorvastatin and simvastatin as analgesic agents in experimental models

  2012cites this paper
• Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency

  2012cites this paper
• Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment

  2010cites this paper
• Melatonin interactions with blood pressure and vascular function during l‐NAME‐induced hypertension

  2010cites this paper
• Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril

  2010cites this paper
• No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.

  2010cites this paper
• Role of modulation of vascular endothelial growth factor and tumor necrosis factor-alpha in gastric ulcer healing in diabetic rats.

  2010cites this paper
• Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment

  2009cites this paper
• Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats

  2009cites this paper
• Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats

  2009cites this paper
• Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats

  2009cites this paper
• Regression of L-NAME–Induced Hypertension: The Role of Nitric Oxide and Endothelium-Derived Constricting Factor

  2008cites this paper
• Participation of nitric oxide in different models of experimental hypertension.

  2008cites this paper
• Regression of left ventricular hypertrophy and aortic remodelling in NO‐deficient hypertensive rats: effect of l‐arginine and spironolactone

  2008cites this paper
• Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.

  2008cites this paper
• Effect of Blood Pressure on L-NAME-sensitive component of relaxation in adult rats

  2007cites this paper
• Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.

  2007cites this paper
• Effect of blood pressure on L-NAME-sensitive component of vasorelaxation in adult rats.

  2007cites this paper
• Simvastatin decreased coenzyme Q in the left ventricle and skeletal muscle but not in the brain and liver in L-NAME-induced hypertension.

  2007cites this paper
• Is NO the king? Pathophysiological benefit with uncertain clinical impact.

  2007cites this paper
• Statins: a perspective for left ventricular hypertrophy treatment

  2007cites this paper
• Enhanced acetylcholine‐induced dilation in afferent arterioles in simvastatin fed rats

  2006cites this paper
• Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.

  2006influential citation
• Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.

  2006cites this paper
• Statins: another class of antihypertensive agents?

  2006cites this paper
• The effect of different antioxidants on nitric oxide production in hypertensive rats.

  2006cites this paper
• The statins - therapeutic diversity in renal disease?

  2005cites this paper
• Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodelling and glomeruli loss in spontaneously hypertensive rats.

  2005cites this paper
• Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ace-inhibition

  2005cites this paper
• Statins and Modulation of Oxidative Stress

  2005cites this paper
• l‐Arginine fails to protect against myocardial remodelling in l‐NAME‐induced hypertension

  2005cites this paper
• Renoprotective Effect of Pravastatin in Salt-Loaded Dahl Salt-Sensitive Rats

  2005cites this paper
• Renal endothelial effects of antihypertensive therapy

  2004cites this paper
• Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats.

  2004cites this paper
• Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ACE-inhibition.

  2004cites this paper